PMC:7172841 / 857-1013 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":11,"end":17},"obj":"Body_part"},{"id":"T10","span":{"begin":28,"end":31},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"-2 patient plasma inhibited HLA-DR expression, and this was partially restored by the IL-6 blocker Tocilizumab; off-label Tocilizumab treatment of patients "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T10","span":{"begin":11,"end":17},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T11","span":{"begin":116,"end":121},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":"-2 patient plasma inhibited HLA-DR expression, and this was partially restored by the IL-6 blocker Tocilizumab; off-label Tocilizumab treatment of patients "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":32,"end":34},"obj":"Chemical"},{"id":"T6","span":{"begin":86,"end":88},"obj":"Chemical"},{"id":"T8","span":{"begin":116,"end":121},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A7","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"}],"text":"-2 patient plasma inhibited HLA-DR expression, and this was partially restored by the IL-6 blocker Tocilizumab; off-label Tocilizumab treatment of patients "}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T30","span":{"begin":11,"end":17},"obj":"UBERON:0001969"},{"id":"T31","span":{"begin":28,"end":31},"obj":"PR:000029150"},{"id":"T32","span":{"begin":35,"end":45},"obj":"GO:0010467"},{"id":"T33","span":{"begin":86,"end":90},"obj":"PR:000001393"},{"id":"T34","span":{"begin":99,"end":110},"obj":"DG_35"},{"id":"T35","span":{"begin":122,"end":133},"obj":"DG_35"},{"id":"T29939","span":{"begin":11,"end":17},"obj":"UBERON:0001969"},{"id":"T8998","span":{"begin":28,"end":31},"obj":"PR:000029150"},{"id":"T62491","span":{"begin":35,"end":45},"obj":"GO:0010467"},{"id":"T78149","span":{"begin":86,"end":90},"obj":"PR:000001393"},{"id":"T18501","span":{"begin":99,"end":110},"obj":"DG_35"},{"id":"T10312","span":{"begin":122,"end":133},"obj":"DG_35"}],"text":"-2 patient plasma inhibited HLA-DR expression, and this was partially restored by the IL-6 blocker Tocilizumab; off-label Tocilizumab treatment of patients "}

{"project":"LitCovid-PubTator","denotations":[{"id":"42","span":{"begin":86,"end":90},"obj":"Gene"},{"id":"47","span":{"begin":3,"end":10},"obj":"Species"},{"id":"48","span":{"begin":147,"end":155},"obj":"Species"},{"id":"51","span":{"begin":99,"end":110},"obj":"Chemical"},{"id":"52","span":{"begin":122,"end":133},"obj":"Chemical"}],"attributes":[{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"Gene:3569"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"Tax:9606"},{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"Tax:9606"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:C502936"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"-2 patient plasma inhibited HLA-DR expression, and this was partially restored by the IL-6 blocker Tocilizumab; off-label Tocilizumab treatment of patients "}